SINT - Sintx Technologies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.3900
+0.0400 (+1.70%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.3500
Open2.3300
Bid2.3500 x 1100
Ask2.4400 x 900
Day's Range2.2600 - 2.9800
52 Week Range1.2500 - 12.3000
Volume1,935,132
Avg. Volume1,152,887
Market Cap4.679M
Beta (3Y Monthly)1.40
PE Ratio (TTM)N/A
EPS (TTM)-31.8600
Earnings DateNov 12, 2019 - Nov 18, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Trade prices are not sourced from all markets
  • Benzinga

    A Look At Benzinga Pro's Most-Searched Tickers For September 13, 2019

    This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Sintx Technologies (NASDAQ: SINT ) shares ...

  • Benzinga

    Why This Analyst Set A $3 Price Target On SINTX Shares

    The FDA-registered silicon nitride medical device manufacturing facility company SINTX Technologies Inc (NASDAQ: SINT ) boasts five near-term catalysts that should help the stock double in value, according ...

  • GlobeNewswire

    SINTX TECHNOLOGIES ANNOUNCES ENGAGEMENT OF ASCENDIANT CAPITAL TO PURSUE DENTAL PARTNERSHIPS

    SINTX Technologies, Inc. (SINT) (the “Company”), an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications, today announced that it has retained Ascendiant Capital Markets, LLC of Irvine, California, Member FINRA & SIPC (“Ascendiant Capital”), as investment bank and advisor, to identify strategic opportunities in the dental space. “While we have been working closely with dental implant companies in specific development projects, Ascendiant Capital will play a critical role in disseminating our R&D advancements to a wider audience of partners, and helping commercialize the technology,” stated Dr. Sonny Bal, President and CEO of SINTX. “We are excited to represent SINTX Technologies, having deep experience and knowledge of dental companies worldwide,” said Dr. Christopher Gayde, a former practicing dentist and Managing Director of Ascendiant Capital’s Dental Investment Banking Group.

  • Benzinga

    A Look At Benzinga Pro's Most-Searched Tickers For September 9, 2019

    This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. ACADIA Pharmaceuticals (NASDAQ: ACAD ) shares ...

  • GlobeNewswire

    SINTX TECHNOLOGIES PROVIDES UPDATES ON PATENT FILINGS

    SINTX Technologies, Inc. (SINT) (the “Company”), an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications, today provided an update on its patent portfolio. The Company announced the provisional filing of a new patent titled “Methods of Surface Functionalization of Zirconia-Toughened Alumina with Silicon Nitride.” “This innovation expands the scope of our technology yet further, by enabling the surface transformation of zirconia-toughened alumina (ZTA), a material widely used in hip replacements worldwide,” said Dr. Sonny Bal, Chairman of SINTX Technologies. “ZTA has proven durability as a weight-bearing implant for decades, but its surface chemistry precludes bone healing.

  • Benzinga

    Another Case For Consistent Trading

    Warrior Trading is a content partner of Benzinga. This post did not go through the Benzinga Newsdesk. Well, it took a half a month of struggles, but this Thursday marks the first time in August that I’ve ...

  • Benzinga

    A Look At Benzinga Pro's Most-Searched Tickers For August 16, 2019

    This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. NVIDIA (NASDAQ: NVDA ) shares were up 5.7% ...

  • GlobeNewswire

    SINTX TECHNOLOGIES RELEASES 2019 YTD EARNINGS REPORT

    SINTX Technologies, Inc. (SINT) (the “Company”), an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications, today announced financial results for the three and six months ended June 30, 2019 and that it received notice from Nasdaq Regulation that it is now compliant with the minimum bid price requirement for continued listing on the Nasdaq Stock Market. For the six months ended June 30, 2019, the Company reported GAAP basic net loss from continuing operations of $2.84 per share, compared to a basic net loss from continuing operations of $36.66 per share for the six months ended June 30, 2018. The Company's cash and cash equivalents were $3.2 million as of June 30, 2019, a decrease of $2.2 million from December 31, 2018.

  • GlobeNewswire

    SINTX TECHNOLOGIES PROVIDES BUSINESS UPDATE

    SINTX Technologies, Inc. (SINT) today provided a business update. The update provides a broad overview of SINTX Technologies, Inc. (“the Company”), its technologies, and the commercial opportunities ahead. “SINTX leads in advanced silicon nitride ceramics and related technologies,” said Dr. Sonny Bal, President and CEO of SINTX.

  • GlobeNewswire

    SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE TODAY

    SALT LAKE CITY, July 26, 2019 (GLOBE NEWSWIRE) --  SINTX Technologies, Inc. (SINT) today announced that its Board of Directors has declared a 1-for-30 reverse stock split of the company’s common stock. The reverse stock split will become effective today, July 26, 2019 (the “Effective Date”) at 5:00 PM Eastern Time. The reverse stock split is primarily intended to bring the company into compliance with the minimum bid price requirements for maintaining its listing on the Nasdaq Global Market.

  • GlobeNewswire

    SINTX TECHNOLOGIES ANNOUNCES STOCKHOLDERS APPROVE REVERSE STOCK SPLIT

    SINTX Technologies, Inc. (SINT) today announced that its stockholders voted in favor of granting the Board of Directors the authority to effect a reverse stock split of the company’s issued and outstanding shares. The Company also announced the promotion of Mr. David O’Brien from Vice President and General Manager to Chief Operating Officer. At the 2019 Annual Meeting of Stockholders that was reconvened on July 12, 2019, the stockholders of SINTX Technologies voted in favor of granting the Board of Directors the authority to effect a reverse stock split of the company’s issued and outstanding shares of its common stock, at a ratio of between 1-for-2 and 1-for-30.

  • GlobeNewswire

    SINTX TECHNOLOGIES ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF STOCKHOLDERS UNTIL JULY 12, 2019

    SINTX Technologies, Inc. (SINT) today announced that its 2019 Annual Meeting of Stockholders ("Annual Meeting"), was adjourned with respect to Proposal 2 - Approval of Reverse Stock Split. While Proposal 2 has exceeded 69% approval based on votes cast to date, approval of more than 50% of all outstanding shares of SINTX common stock as of March 6, 2019, is necessary for the proposal to be ratified and approved. The adjournment will allow for the solicitation of additional votes on Proposal 2.

  • GlobeNewswire

    SINTX TECHNOLOGIES ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF STOCKHOLDERS UNTIL JULY 3, 2019

    SINTX Technologies, Inc. (SINT) today announced that its 2019 Annual Meeting of Stockholders ("Annual Meeting"), was adjourned with respect to Proposal 2 - Approval of Reverse Stock Split. While Proposal 2 has exceeded 68% approval based on votes cast to date, approval of more than 50% of all outstanding shares of SINTX common stock as of March 6, 2019, is necessary for the proposal to be ratified and approved. The adjournment will allow for the solicitation of additional votes on Proposal 2.

  • GlobeNewswire

    SINTX TECHNOLOGIES RENEWS LEASE WITH PORTFOLIO INVESTMENTS AT CENTREPOINTE BUSINESS PARK

    SINTX Technologies, Inc., a ceramics OEM company that develops and manufactures silicon nitride, announced today that the Company renewed its lease with Portfolio Investments at Centrepointe Business Park in Salt Lake City, Utah, for a five year term. The Company will lease a smaller section of the building consistent with a new footprint following the sale of its retail spine business and re-branding last year. Dr. Sonny Bal, President & CEO, said “This is a milestone for SINTX.

  • GlobeNewswire

    SINTX TECHNOLOGIES ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF STOCKHOLDERS UNTIL MAY 23, 2019

    SALT LAKE CITY, April 24, 2019 (GLOBE NEWSWIRE) --  SINTX Technologies, Inc. (SINT) today announced that its 2019 Annual Meeting of Stockholders ("Annual Meeting"), scheduled for Tuesday, April 23, 2019, was convened on Proposals 1, 3 and 4 each as set forth in the company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on March 25, 2019 with all such proposals having been ratified and approved. The company adjourned the Annual Meeting with respect to Proposal 2 - Approval of Reverse Stock Split. While Proposal 2 has exceeded 60% approval based on votes cast to date, approval of more than 50% of all outstanding shares of SINTX common stock as of March 6, 2019, is necessary for the proposal to be ratified and approved.

  • GlobeNewswire

    SINTX TECHNOLOGIES HIRES STRATEGIC VP

    SALT LAKE CITY , April 15, 2019 -- SINTX Technologies, Inc. (NASDAQ: SINT) announced today that it has hired Donald J. Bray as Vice President of Business Development. Mr. Bray.

  • GlobeNewswire

    SINTX AND EU CONSORTIUM COLLABORATE IN SILICON NITRIDE DEVELOPMENT

    SINTX Technologies, an innovative biomaterials and OEM company that develops and manufactures biomedical silicon nitride, announced a key partnership with a multi-center European industry-academic group that aims to train future scientists, and promote the development of silicon nitride biomedical implants. As partner and senior advisor to the program, SINTX will participate in technical reviews of the program, and will host graduate students during the course of the program. Silicon nitride offers the mechanical strength, chemical stability, and biocompatibility needed to manufacture spinal implants.

  • GlobeNewswire

    SINTX ANNOUNCES 30-YEAR SPINE FUSION DATA WITH SILICON NITRIDE IMPLANTS

    SINTX Technologies (SINT) today reported the independent publication of 30-year clinical outcomes of lumbar fusion surgeries, performed with silicon nitride implants. The paper titled “Anterior Lumbar Interbody Fusion Using Reaction Bonded Silicon Nitride Implants” appeared in the December 2018 edition of the World Neurosurgery journal, and the findings were also featured at the 2018 Annual Scientific Meeting of the Neurosurgical Society of Australasia. Dr. Ralph Mobbs from the University of New South Wales, Sydney, authored the study.